SLIT2 and lung carcinoma: In this study, we identified F-LT1-3, a peptide derived from the Slit2-LamG domain, which exhibits dual roles in inhibiting the proliferation and invasion of lung cancer cells but not in inhibiting the proliferation of normal cell types.